nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0427	0.065	CbGbCtD
Fluphenazine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0383	0.0583	CbGbCtD
Fluphenazine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0361	0.0548	CbGbCtD
Fluphenazine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0361	0.0548	CbGbCtD
Fluphenazine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0326	0.0496	CbGbCtD
Fluphenazine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0316	0.0481	CbGbCtD
Fluphenazine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0315	0.0479	CbGbCtD
Fluphenazine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0297	0.0452	CbGbCtD
Fluphenazine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0297	0.0452	CbGbCtD
Fluphenazine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0285	0.0434	CbGbCtD
Fluphenazine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0273	0.0416	CbGbCtD
Fluphenazine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0269	0.0409	CbGbCtD
Fluphenazine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0269	0.0409	CbGbCtD
Fluphenazine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0247	0.0376	CbGbCtD
Fluphenazine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0246	0.0374	CbGbCtD
Fluphenazine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0239	0.0363	CbGbCtD
Fluphenazine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0232	0.0353	CbGbCtD
Fluphenazine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0225	0.0342	CbGbCtD
Fluphenazine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0216	0.0329	CbGbCtD
Fluphenazine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0216	0.0329	CbGbCtD
Fluphenazine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0207	0.0315	CbGbCtD
Fluphenazine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0204	0.031	CbGbCtD
Fluphenazine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0204	0.031	CbGbCtD
Fluphenazine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.016	0.0244	CbGbCtD
Fluphenazine—CALM2—semen—acquired immunodeficiency syndrome	0.00454	0.0512	CbGeAlD
Fluphenazine—CALM1—semen—acquired immunodeficiency syndrome	0.00451	0.051	CbGeAlD
Fluphenazine—DRD1—nerve—acquired immunodeficiency syndrome	0.0034	0.0384	CbGeAlD
Fluphenazine—CALM2—nerve—acquired immunodeficiency syndrome	0.00219	0.0247	CbGeAlD
Fluphenazine—CALM1—nerve—acquired immunodeficiency syndrome	0.00218	0.0246	CbGeAlD
Fluphenazine—DRD2—nerve—acquired immunodeficiency syndrome	0.00201	0.0227	CbGeAlD
Fluphenazine—CALM2—endothelium—acquired immunodeficiency syndrome	0.00186	0.021	CbGeAlD
Fluphenazine—CALM1—endothelium—acquired immunodeficiency syndrome	0.00185	0.0209	CbGeAlD
Fluphenazine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00168	0.019	CbGeAlD
Fluphenazine—CALM2—blood plasma—acquired immunodeficiency syndrome	0.00165	0.0187	CbGeAlD
Fluphenazine—CALM1—blood plasma—acquired immunodeficiency syndrome	0.00165	0.0186	CbGeAlD
Fluphenazine—HTR2A—nerve—acquired immunodeficiency syndrome	0.00133	0.015	CbGeAlD
Fluphenazine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00128	0.0145	CbGeAlD
Fluphenazine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00118	0.0133	CbGeAlD
Fluphenazine—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.00115	0.013	CbGeAlD
Fluphenazine—CALM3—retina—acquired immunodeficiency syndrome	0.00115	0.013	CbGeAlD
Fluphenazine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00113	0.0127	CbGeAlD
Fluphenazine—DRD3—nervous system—acquired immunodeficiency syndrome	0.00107	0.0121	CbGeAlD
Fluphenazine—DRD3—central nervous system—acquired immunodeficiency syndrome	0.00103	0.0116	CbGeAlD
Fluphenazine—HTR6—nervous system—acquired immunodeficiency syndrome	0.00103	0.0116	CbGeAlD
Fluphenazine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.001	0.0113	CbGeAlD
Fluphenazine—HTR6—central nervous system—acquired immunodeficiency syndrome	0.00099	0.0112	CbGeAlD
Fluphenazine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000913	0.0103	CbGeAlD
Fluphenazine—CALM2—retina—acquired immunodeficiency syndrome	0.000905	0.0102	CbGeAlD
Fluphenazine—CALM1—retina—acquired immunodeficiency syndrome	0.000901	0.0102	CbGeAlD
Fluphenazine—Renal failure acute—Indinavir—acquired immunodeficiency syndrome	0.000856	0.00443	CcSEcCtD
Fluphenazine—Polyuria—Efavirenz—acquired immunodeficiency syndrome	0.000851	0.00441	CcSEcCtD
Fluphenazine—DRD2—retina—acquired immunodeficiency syndrome	0.000832	0.00939	CbGeAlD
Fluphenazine—Eczema—Efavirenz—acquired immunodeficiency syndrome	0.000831	0.0043	CcSEcCtD
Fluphenazine—Urine output increased—Ritonavir—acquired immunodeficiency syndrome	0.000823	0.00426	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Indinavir—acquired immunodeficiency syndrome	0.000817	0.00423	CcSEcCtD
Fluphenazine—DRD3—brain—acquired immunodeficiency syndrome	0.000816	0.00922	CbGeAlD
Fluphenazine—Polyuria—Delavirdine—acquired immunodeficiency syndrome	0.000814	0.00422	CcSEcCtD
Fluphenazine—Agranulocytosis—Didanosine—acquired immunodeficiency syndrome	0.00081	0.0042	CcSEcCtD
Fluphenazine—Renal failure acute—Efavirenz—acquired immunodeficiency syndrome	0.000809	0.00419	CcSEcCtD
Fluphenazine—CALM2—skin of body—acquired immunodeficiency syndrome	0.000795	0.00897	CbGeAlD
Fluphenazine—Dermatitis exfoliative—Efavirenz—acquired immunodeficiency syndrome	0.000792	0.0041	CcSEcCtD
Fluphenazine—CALM1—skin of body—acquired immunodeficiency syndrome	0.000791	0.00893	CbGeAlD
Fluphenazine—HTR6—brain—acquired immunodeficiency syndrome	0.000786	0.00887	CbGeAlD
Fluphenazine—Renal failure acute—Delavirdine—acquired immunodeficiency syndrome	0.000774	0.00401	CcSEcCtD
Fluphenazine—CALM3—blood—acquired immunodeficiency syndrome	0.000771	0.0087	CbGeAlD
Fluphenazine—DRD1—nervous system—acquired immunodeficiency syndrome	0.000765	0.00864	CbGeAlD
Fluphenazine—Pneumonia—Nelfinavir—acquired immunodeficiency syndrome	0.00076	0.00394	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Delavirdine—acquired immunodeficiency syndrome	0.000757	0.00392	CcSEcCtD
Fluphenazine—Urine output increased—Lamivudine—acquired immunodeficiency syndrome	0.000756	0.00391	CcSEcCtD
Fluphenazine—Polyuria—Ritonavir—acquired immunodeficiency syndrome	0.000753	0.0039	CcSEcCtD
Fluphenazine—Gynaecomastia—Lamivudine—acquired immunodeficiency syndrome	0.000748	0.00387	CcSEcCtD
Fluphenazine—Pneumonia—Abacavir—acquired immunodeficiency syndrome	0.000747	0.00387	CcSEcCtD
Fluphenazine—CALM3—bone marrow—acquired immunodeficiency syndrome	0.000746	0.00842	CbGeAlD
Fluphenazine—CALM3—spinal cord—acquired immunodeficiency syndrome	0.000743	0.00839	CbGeAlD
Fluphenazine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000736	0.00831	CbGeAlD
Fluphenazine—Eczema—Ritonavir—acquired immunodeficiency syndrome	0.000735	0.00381	CcSEcCtD
Fluphenazine—Dysphagia—Zidovudine—acquired immunodeficiency syndrome	0.000735	0.00381	CcSEcCtD
Fluphenazine—Lethargy—Delavirdine—acquired immunodeficiency syndrome	0.000729	0.00378	CcSEcCtD
Fluphenazine—Agranulocytosis—Nevirapine—acquired immunodeficiency syndrome	0.000728	0.00377	CcSEcCtD
Fluphenazine—Renal failure acute—Ritonavir—acquired immunodeficiency syndrome	0.000716	0.00371	CcSEcCtD
Fluphenazine—CALM3—vagina—acquired immunodeficiency syndrome	0.000715	0.00807	CbGeAlD
Fluphenazine—Disturbance in sexual arousal—Delavirdine—acquired immunodeficiency syndrome	0.000709	0.00367	CcSEcCtD
Fluphenazine—Eczema—Saquinavir—acquired immunodeficiency syndrome	0.000708	0.00367	CcSEcCtD
Fluphenazine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000705	0.00796	CbGeAlD
Fluphenazine—Dermatitis exfoliative—Ritonavir—acquired immunodeficiency syndrome	0.0007	0.00363	CcSEcCtD
Fluphenazine—Pancytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000698	0.00361	CcSEcCtD
Fluphenazine—Polyuria—Lamivudine—acquired immunodeficiency syndrome	0.000691	0.00358	CcSEcCtD
Fluphenazine—Renal failure acute—Saquinavir—acquired immunodeficiency syndrome	0.000689	0.00357	CcSEcCtD
Fluphenazine—Angioedema—Amprenavir—acquired immunodeficiency syndrome	0.00068	0.00352	CcSEcCtD
Fluphenazine—CALM3—lung—acquired immunodeficiency syndrome	0.000676	0.00763	CbGeAlD
Fluphenazine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000657	0.00741	CbGeAlD
Fluphenazine—Disturbance in sexual arousal—Ritonavir—acquired immunodeficiency syndrome	0.000656	0.0034	CcSEcCtD
Fluphenazine—Lethargy—Saquinavir—acquired immunodeficiency syndrome	0.000649	0.00336	CcSEcCtD
Fluphenazine—Asthma—Efavirenz—acquired immunodeficiency syndrome	0.000646	0.00334	CcSEcCtD
Fluphenazine—CALM2—lymphoid tissue—acquired immunodeficiency syndrome	0.000643	0.00726	CbGeAlD
Fluphenazine—CALM1—lymphoid tissue—acquired immunodeficiency syndrome	0.00064	0.00723	CbGeAlD
Fluphenazine—CALM2—digestive system—acquired immunodeficiency syndrome	0.000636	0.00718	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Indinavir—acquired immunodeficiency syndrome	0.000635	0.00329	CcSEcCtD
Fluphenazine—CALM1—digestive system—acquired immunodeficiency syndrome	0.000633	0.00714	CbGeAlD
Fluphenazine—Disturbance in sexual arousal—Saquinavir—acquired immunodeficiency syndrome	0.000631	0.00327	CcSEcCtD
Fluphenazine—Dysphagia—Delavirdine—acquired immunodeficiency syndrome	0.000618	0.0032	CcSEcCtD
Fluphenazine—Pancytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000613	0.00318	CcSEcCtD
Fluphenazine—Pneumonia—Indinavir—acquired immunodeficiency syndrome	0.000613	0.00317	CcSEcCtD
Fluphenazine—Eosinophilia—Delavirdine—acquired immunodeficiency syndrome	0.000612	0.00317	CcSEcCtD
Fluphenazine—Agranulocytosis—Zidovudine—acquired immunodeficiency syndrome	0.000611	0.00317	CcSEcCtD
Fluphenazine—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.00061	0.00316	CcSEcCtD
Fluphenazine—Leukopenia—Didanosine—acquired immunodeficiency syndrome	0.000607	0.00315	CcSEcCtD
Fluphenazine—CALM2—blood—acquired immunodeficiency syndrome	0.000605	0.00684	CbGeAlD
Fluphenazine—CALM1—blood—acquired immunodeficiency syndrome	0.000603	0.0068	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Efavirenz—acquired immunodeficiency syndrome	0.0006	0.00311	CcSEcCtD
Fluphenazine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000594	0.00671	CbGeAlD
Fluphenazine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000593	0.0067	CbGeAlD
Fluphenazine—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.000591	0.00306	CcSEcCtD
Fluphenazine—Skin disorder—Amprenavir—acquired immunodeficiency syndrome	0.00059	0.00306	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Efavirenz—acquired immunodeficiency syndrome	0.000589	0.00305	CcSEcCtD
Fluphenazine—Pancytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000587	0.00304	CcSEcCtD
Fluphenazine—CALM2—bone marrow—acquired immunodeficiency syndrome	0.000586	0.00661	CbGeAlD
Fluphenazine—DRD1—brain—acquired immunodeficiency syndrome	0.000585	0.0066	CbGeAlD
Fluphenazine—CALM2—spinal cord—acquired immunodeficiency syndrome	0.000583	0.00659	CbGeAlD
Fluphenazine—CALM1—bone marrow—acquired immunodeficiency syndrome	0.000583	0.00658	CbGeAlD
Fluphenazine—CALM1—spinal cord—acquired immunodeficiency syndrome	0.000581	0.00656	CbGeAlD
Fluphenazine—Pneumonia—Efavirenz—acquired immunodeficiency syndrome	0.000579	0.003	CcSEcCtD
Fluphenazine—Drowsiness—Efavirenz—acquired immunodeficiency syndrome	0.000576	0.00298	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Delavirdine—acquired immunodeficiency syndrome	0.000574	0.00297	CcSEcCtD
Fluphenazine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000572	0.00646	CbGeAlD
Fluphenazine—Dysphagia—Ritonavir—acquired immunodeficiency syndrome	0.000571	0.00296	CcSEcCtD
Fluphenazine—Asthma—Ritonavir—acquired immunodeficiency syndrome	0.000571	0.00296	CcSEcCtD
Fluphenazine—Muscle spasms—Nelfinavir—acquired immunodeficiency syndrome	0.000568	0.00294	CcSEcCtD
Fluphenazine—Dry mouth—Didanosine—acquired immunodeficiency syndrome	0.000565	0.00293	CcSEcCtD
Fluphenazine—CALM2—vagina—acquired immunodeficiency syndrome	0.000561	0.00634	CbGeAlD
Fluphenazine—CALM1—vagina—acquired immunodeficiency syndrome	0.000559	0.00631	CbGeAlD
Fluphenazine—Angioedema—Nevirapine—acquired immunodeficiency syndrome	0.000557	0.00289	CcSEcCtD
Fluphenazine—Pneumonia—Delavirdine—acquired immunodeficiency syndrome	0.000554	0.00287	CcSEcCtD
Fluphenazine—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.000554	0.00287	CcSEcCtD
Fluphenazine—Asthma—Saquinavir—acquired immunodeficiency syndrome	0.00055	0.00285	CcSEcCtD
Fluphenazine—Dysphagia—Saquinavir—acquired immunodeficiency syndrome	0.00055	0.00285	CcSEcCtD
Fluphenazine—HTR2A—retina—acquired immunodeficiency syndrome	0.000549	0.0062	CbGeAlD
Fluphenazine—Agitation—Nelfinavir—acquired immunodeficiency syndrome	0.000543	0.00281	CcSEcCtD
Fluphenazine—CALM2—lung—acquired immunodeficiency syndrome	0.000531	0.00599	CbGeAlD
Fluphenazine—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000529	0.00274	CcSEcCtD
Fluphenazine—CALM1—lung—acquired immunodeficiency syndrome	0.000528	0.00596	CbGeAlD
Fluphenazine—Decreased appetite—Amprenavir—acquired immunodeficiency syndrome	0.000528	0.00273	CcSEcCtD
Fluphenazine—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.000527	0.00273	CcSEcCtD
Fluphenazine—Dysphagia—Lamivudine—acquired immunodeficiency syndrome	0.000524	0.00272	CcSEcCtD
Fluphenazine—Pancytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000522	0.0027	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Ritonavir—acquired immunodeficiency syndrome	0.000521	0.0027	CcSEcCtD
Fluphenazine—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.000519	0.00269	CcSEcCtD
Fluphenazine—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.000512	0.00265	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Saquinavir—acquired immunodeficiency syndrome	0.000511	0.00265	CcSEcCtD
Fluphenazine—Oedema peripheral—Efavirenz—acquired immunodeficiency syndrome	0.000509	0.00264	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Saquinavir—acquired immunodeficiency syndrome	0.000502	0.0026	CcSEcCtD
Fluphenazine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.0005	0.00565	CbGeAlD
Fluphenazine—Pancytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000498	0.00258	CcSEcCtD
Fluphenazine—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.000498	0.00258	CcSEcCtD
Fluphenazine—Pneumonia—Saquinavir—acquired immunodeficiency syndrome	0.000493	0.00255	CcSEcCtD
Fluphenazine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000493	0.00556	CbGeAlD
Fluphenazine—Muscle spasms—Zidovudine—acquired immunodeficiency syndrome	0.000492	0.00255	CcSEcCtD
Fluphenazine—CALM2—nervous system—acquired immunodeficiency syndrome	0.000491	0.00555	CbGeAlD
Fluphenazine—Dry mouth—Stavudine—acquired immunodeficiency syndrome	0.00049	0.00254	CcSEcCtD
Fluphenazine—CALM1—nervous system—acquired immunodeficiency syndrome	0.000489	0.00552	CbGeAlD
Fluphenazine—DRD2—lung—acquired immunodeficiency syndrome	0.000488	0.00551	CbGeAlD
Fluphenazine—Oedema peripheral—Delavirdine—acquired immunodeficiency syndrome	0.000487	0.00252	CcSEcCtD
Fluphenazine—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000484	0.0025	CcSEcCtD
Fluphenazine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000481	0.00544	CbGeAlD
Fluphenazine—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.000481	0.00249	CcSEcCtD
Fluphenazine—CALM3—brain—acquired immunodeficiency syndrome	0.000478	0.0054	CbGeAlD
Fluphenazine—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.000474	0.00245	CcSEcCtD
Fluphenazine—CALM2—central nervous system—acquired immunodeficiency syndrome	0.000473	0.00534	CbGeAlD
Fluphenazine—CALM1—central nervous system—acquired immunodeficiency syndrome	0.000471	0.00532	CbGeAlD
Fluphenazine—CYP1A2—blood—acquired immunodeficiency syndrome	0.00047	0.0053	CbGeAlD
Fluphenazine—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000468	0.00243	CcSEcCtD
Fluphenazine—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.000468	0.00242	CcSEcCtD
Fluphenazine—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000467	0.00242	CcSEcCtD
Fluphenazine—CALM3—lymph node—acquired immunodeficiency syndrome	0.000462	0.00522	CbGeAlD
Fluphenazine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000461	0.00521	CbGeAlD
Fluphenazine—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00046	0.00238	CcSEcCtD
Fluphenazine—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000458	0.00237	CcSEcCtD
Fluphenazine—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.000458	0.00237	CcSEcCtD
Fluphenazine—HTR2C—brain—acquired immunodeficiency syndrome	0.000454	0.00513	CbGeAlD
Fluphenazine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000452	0.0051	CbGeAlD
Fluphenazine—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.00045	0.00233	CcSEcCtD
Fluphenazine—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00045	0.00233	CcSEcCtD
Fluphenazine—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000449	0.00507	CbGeAlD
Fluphenazine—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.000449	0.00232	CcSEcCtD
Fluphenazine—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000443	0.00501	CbGeAlD
Fluphenazine—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000443	0.00229	CcSEcCtD
Fluphenazine—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000442	0.00229	CcSEcCtD
Fluphenazine—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000438	0.00227	CcSEcCtD
Fluphenazine—Agitation—Indinavir—acquired immunodeficiency syndrome	0.000438	0.00227	CcSEcCtD
Fluphenazine—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000436	0.00226	CcSEcCtD
Fluphenazine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000435	0.00491	CbGeAlD
Fluphenazine—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000435	0.00225	CcSEcCtD
Fluphenazine—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000433	0.00224	CcSEcCtD
Fluphenazine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000432	0.00488	CbGeAlD
Fluphenazine—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00043	0.00223	CcSEcCtD
Fluphenazine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00043	0.00223	CcSEcCtD
Fluphenazine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00043	0.00223	CcSEcCtD
Fluphenazine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000429	0.00222	CcSEcCtD
Fluphenazine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000427	0.00221	CcSEcCtD
Fluphenazine—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.000424	0.0022	CcSEcCtD
Fluphenazine—CYP2E1—blood—acquired immunodeficiency syndrome	0.000422	0.00477	CbGeAlD
Fluphenazine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000422	0.00219	CcSEcCtD
Fluphenazine—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000419	0.00217	CcSEcCtD
Fluphenazine—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000418	0.00216	CcSEcCtD
Fluphenazine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000418	0.00216	CcSEcCtD
Fluphenazine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000416	0.0047	CbGeAlD
Fluphenazine—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000414	0.00214	CcSEcCtD
Fluphenazine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000413	0.00214	CcSEcCtD
Fluphenazine—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000412	0.00213	CcSEcCtD
Fluphenazine—CYP1A2—lung—acquired immunodeficiency syndrome	0.000412	0.00465	CbGeAlD
Fluphenazine—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000411	0.00213	CcSEcCtD
Fluphenazine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000411	0.00213	CcSEcCtD
Fluphenazine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000408	0.00211	CcSEcCtD
Fluphenazine—HRH1—vagina—acquired immunodeficiency syndrome	0.000407	0.0046	CbGeAlD
Fluphenazine—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000407	0.00459	CbGeAlD
Fluphenazine—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000406	0.0021	CcSEcCtD
Fluphenazine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000406	0.0021	CcSEcCtD
Fluphenazine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.0004	0.00452	CbGeAlD
Fluphenazine—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000396	0.00205	CcSEcCtD
Fluphenazine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000396	0.00205	CcSEcCtD
Fluphenazine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000395	0.00205	CcSEcCtD
Fluphenazine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000394	0.00204	CcSEcCtD
Fluphenazine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000393	0.00204	CcSEcCtD
Fluphenazine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000392	0.00203	CcSEcCtD
Fluphenazine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000389	0.00201	CcSEcCtD
Fluphenazine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000388	0.00201	CcSEcCtD
Fluphenazine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000385	0.00435	CbGeAlD
Fluphenazine—HRH1—lung—acquired immunodeficiency syndrome	0.000385	0.00435	CbGeAlD
Fluphenazine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000385	0.002	CcSEcCtD
Fluphenazine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000383	0.00198	CcSEcCtD
Fluphenazine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000383	0.00198	CcSEcCtD
Fluphenazine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000383	0.00198	CcSEcCtD
Fluphenazine—HTR1A—brain—acquired immunodeficiency syndrome	0.000382	0.00432	CbGeAlD
Fluphenazine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000382	0.00198	CcSEcCtD
Fluphenazine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000381	0.00197	CcSEcCtD
Fluphenazine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00038	0.00197	CcSEcCtD
Fluphenazine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00038	0.00197	CcSEcCtD
Fluphenazine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000379	0.00427	CbGeAlD
Fluphenazine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000377	0.00195	CcSEcCtD
Fluphenazine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000376	0.00195	CcSEcCtD
Fluphenazine—CALM2—brain—acquired immunodeficiency syndrome	0.000376	0.00424	CbGeAlD
Fluphenazine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000375	0.00194	CcSEcCtD
Fluphenazine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000375	0.00194	CcSEcCtD
Fluphenazine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000374	0.00194	CcSEcCtD
Fluphenazine—CALM1—brain—acquired immunodeficiency syndrome	0.000374	0.00422	CbGeAlD
Fluphenazine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000372	0.00193	CcSEcCtD
Fluphenazine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000372	0.00192	CcSEcCtD
Fluphenazine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000371	0.00192	CcSEcCtD
Fluphenazine—CYP2E1—lung—acquired immunodeficiency syndrome	0.00037	0.00418	CbGeAlD
Fluphenazine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000368	0.00191	CcSEcCtD
Fluphenazine—HTR2A—blood—acquired immunodeficiency syndrome	0.000367	0.00415	CbGeAlD
Fluphenazine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000367	0.0019	CcSEcCtD
Fluphenazine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000366	0.00189	CcSEcCtD
Fluphenazine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000365	0.00189	CcSEcCtD
Fluphenazine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000363	0.00188	CcSEcCtD
Fluphenazine—CALM2—lymph node—acquired immunodeficiency syndrome	0.000363	0.0041	CbGeAlD
Fluphenazine—CALM1—lymph node—acquired immunodeficiency syndrome	0.000361	0.00408	CbGeAlD
Fluphenazine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000361	0.00187	CcSEcCtD
Fluphenazine—ABCB1—retina—acquired immunodeficiency syndrome	0.00036	0.00406	CbGeAlD
Fluphenazine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000358	0.00186	CcSEcCtD
Fluphenazine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000358	0.00186	CcSEcCtD
Fluphenazine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000357	0.00185	CcSEcCtD
Fluphenazine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000357	0.00403	CbGeAlD
Fluphenazine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000357	0.00185	CcSEcCtD
Fluphenazine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000356	0.00185	CcSEcCtD
Fluphenazine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000355	0.00184	CcSEcCtD
Fluphenazine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000354	0.00183	CcSEcCtD
Fluphenazine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000354	0.00399	CbGeAlD
Fluphenazine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000352	0.00182	CcSEcCtD
Fluphenazine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000352	0.00182	CcSEcCtD
Fluphenazine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000351	0.00182	CcSEcCtD
Fluphenazine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000351	0.00396	CbGeAlD
Fluphenazine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000351	0.00396	CbGeAlD
Fluphenazine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000349	0.00181	CcSEcCtD
Fluphenazine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000347	0.0018	CcSEcCtD
Fluphenazine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000346	0.00179	CcSEcCtD
Fluphenazine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000345	0.00179	CcSEcCtD
Fluphenazine—DRD2—brain—acquired immunodeficiency syndrome	0.000345	0.0039	CbGeAlD
Fluphenazine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000344	0.00178	CcSEcCtD
Fluphenazine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000344	0.00388	CbGeAlD
Fluphenazine—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000343	0.00387	CbGeAlD
Fluphenazine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000343	0.00178	CcSEcCtD
Fluphenazine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000343	0.00178	CcSEcCtD
Fluphenazine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000341	0.00177	CcSEcCtD
Fluphenazine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000341	0.00177	CcSEcCtD
Fluphenazine—HTR2A—vagina—acquired immunodeficiency syndrome	0.00034	0.00384	CbGeAlD
Fluphenazine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00034	0.00176	CcSEcCtD
Fluphenazine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000338	0.00175	CcSEcCtD
Fluphenazine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000337	0.00381	CbGeAlD
Fluphenazine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000335	0.00174	CcSEcCtD
Fluphenazine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000334	0.00378	CbGeAlD
Fluphenazine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000334	0.00173	CcSEcCtD
Fluphenazine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000332	0.00172	CcSEcCtD
Fluphenazine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000332	0.00172	CcSEcCtD
Fluphenazine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000331	0.00172	CcSEcCtD
Fluphenazine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000331	0.00171	CcSEcCtD
Fluphenazine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00033	0.00171	CcSEcCtD
Fluphenazine—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.00033	0.00373	CbGeAlD
Fluphenazine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000329	0.0017	CcSEcCtD
Fluphenazine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000328	0.0017	CcSEcCtD
Fluphenazine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.0017	CcSEcCtD
Fluphenazine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000327	0.00169	CcSEcCtD
Fluphenazine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000326	0.00169	CcSEcCtD
Fluphenazine—HTR2A—lung—acquired immunodeficiency syndrome	0.000322	0.00363	CbGeAlD
Fluphenazine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000319	0.00165	CcSEcCtD
Fluphenazine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000319	0.00165	CcSEcCtD
Fluphenazine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000317	0.00164	CcSEcCtD
Fluphenazine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000316	0.00163	CcSEcCtD
Fluphenazine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000314	0.00163	CcSEcCtD
Fluphenazine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000313	0.00162	CcSEcCtD
Fluphenazine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000312	0.00162	CcSEcCtD
Fluphenazine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000312	0.00162	CcSEcCtD
Fluphenazine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000309	0.0016	CcSEcCtD
Fluphenazine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000307	0.00159	CcSEcCtD
Fluphenazine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000305	0.00158	CcSEcCtD
Fluphenazine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000304	0.00158	CcSEcCtD
Fluphenazine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000304	0.00157	CcSEcCtD
Fluphenazine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000304	0.00157	CcSEcCtD
Fluphenazine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000302	0.00156	CcSEcCtD
Fluphenazine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000301	0.00156	CcSEcCtD
Fluphenazine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.0003	0.00156	CcSEcCtD
Fluphenazine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000298	0.00154	CcSEcCtD
Fluphenazine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000298	0.00337	CbGeAlD
Fluphenazine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000297	0.00154	CcSEcCtD
Fluphenazine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000296	0.00153	CcSEcCtD
Fluphenazine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000296	0.00153	CcSEcCtD
Fluphenazine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000292	0.00151	CcSEcCtD
Fluphenazine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000292	0.00151	CcSEcCtD
Fluphenazine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00029	0.0015	CcSEcCtD
Fluphenazine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00029	0.0015	CcSEcCtD
Fluphenazine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.0015	CcSEcCtD
Fluphenazine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.0015	CcSEcCtD
Fluphenazine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000287	0.00324	CbGeAlD
Fluphenazine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000286	0.00148	CcSEcCtD
Fluphenazine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000286	0.00148	CcSEcCtD
Fluphenazine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000286	0.00148	CcSEcCtD
Fluphenazine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000282	0.00146	CcSEcCtD
Fluphenazine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000281	0.00146	CcSEcCtD
Fluphenazine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000279	0.00145	CcSEcCtD
Fluphenazine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.00144	CcSEcCtD
Fluphenazine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.00144	CcSEcCtD
Fluphenazine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.00144	CcSEcCtD
Fluphenazine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.00144	CcSEcCtD
Fluphenazine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000278	0.00144	CcSEcCtD
Fluphenazine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000275	0.00142	CcSEcCtD
Fluphenazine—HRH1—brain—acquired immunodeficiency syndrome	0.000273	0.00308	CbGeAlD
Fluphenazine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000272	0.00141	CcSEcCtD
Fluphenazine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000272	0.00307	CbGeAlD
Fluphenazine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00027	0.0014	CcSEcCtD
Fluphenazine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000268	0.00302	CbGeAlD
Fluphenazine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.00138	CcSEcCtD
Fluphenazine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.00138	CcSEcCtD
Fluphenazine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.00137	CcSEcCtD
Fluphenazine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000264	0.00298	CbGeAlD
Fluphenazine—CYP2E1—brain—acquired immunodeficiency syndrome	0.000262	0.00296	CbGeAlD
Fluphenazine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000262	0.00136	CcSEcCtD
Fluphenazine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000261	0.00295	CbGeAlD
Fluphenazine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.00135	CcSEcCtD
Fluphenazine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.00134	CcSEcCtD
Fluphenazine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000259	0.00292	CbGeAlD
Fluphenazine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.00134	CcSEcCtD
Fluphenazine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.00134	CcSEcCtD
Fluphenazine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.00133	CcSEcCtD
Fluphenazine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000256	0.00289	CbGeAlD
Fluphenazine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.00132	CcSEcCtD
Fluphenazine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000253	0.00285	CbGeAlD
Fluphenazine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.00129	CcSEcCtD
Fluphenazine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.00129	CcSEcCtD
Fluphenazine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000248	0.00129	CcSEcCtD
Fluphenazine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000247	0.00128	CcSEcCtD
Fluphenazine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000243	0.00126	CcSEcCtD
Fluphenazine—ABCB1—blood—acquired immunodeficiency syndrome	0.000241	0.00272	CbGeAlD
Fluphenazine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.00124	CcSEcCtD
Fluphenazine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.00123	CcSEcCtD
Fluphenazine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.00122	CcSEcCtD
Fluphenazine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000233	0.00263	CbGeAlD
Fluphenazine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000232	0.00262	CbGeAlD
Fluphenazine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000231	0.0012	CcSEcCtD
Fluphenazine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.00119	CcSEcCtD
Fluphenazine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.00119	CcSEcCtD
Fluphenazine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.00119	CcSEcCtD
Fluphenazine—HTR2A—brain—acquired immunodeficiency syndrome	0.000228	0.00257	CbGeAlD
Fluphenazine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000223	0.00252	CbGeAlD
Fluphenazine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00115	CcSEcCtD
Fluphenazine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.00114	CcSEcCtD
Fluphenazine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.00114	CcSEcCtD
Fluphenazine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000218	0.00113	CcSEcCtD
Fluphenazine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.00109	CcSEcCtD
Fluphenazine—ABCB1—lung—acquired immunodeficiency syndrome	0.000211	0.00238	CbGeAlD
Fluphenazine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000209	0.00108	CcSEcCtD
Fluphenazine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000208	0.00234	CbGeAlD
Fluphenazine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.00105	CcSEcCtD
Fluphenazine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.00101	CcSEcCtD
Fluphenazine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000195	0.00221	CbGeAlD
Fluphenazine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000999	CcSEcCtD
Fluphenazine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000188	0.00212	CbGeAlD
Fluphenazine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000968	CcSEcCtD
Fluphenazine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000962	CcSEcCtD
Fluphenazine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000918	CcSEcCtD
Fluphenazine—ABCB1—brain—acquired immunodeficiency syndrome	0.000149	0.00169	CbGeAlD
Fluphenazine—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000144	0.00163	CbGeAlD
Fluphenazine—Acepromazine—ALB—acquired immunodeficiency syndrome	0.000109	0.226	CrCbGaD
Fluphenazine—Thioproperazine—ALB—acquired immunodeficiency syndrome	0.000107	0.221	CrCbGaD
Fluphenazine—Pipotiazine—ALB—acquired immunodeficiency syndrome	0.000105	0.217	CrCbGaD
Fluphenazine—Thiothixene—ALB—acquired immunodeficiency syndrome	0.000105	0.217	CrCbGaD
Fluphenazine—Chlorpromazine—ALB—acquired immunodeficiency syndrome	5.7e-05	0.118	CrCbGaD
Fluphenazine—CALM1—Immune System—CCR2—acquired immunodeficiency syndrome	2.45e-05	0.000405	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CCR2—acquired immunodeficiency syndrome	2.45e-05	0.000405	CbGpPWpGaD
Fluphenazine—CALM3—DAP12 interactions—IL6—acquired immunodeficiency syndrome	2.45e-05	0.000405	CbGpPWpGaD
Fluphenazine—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.45e-05	0.000405	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	2.45e-05	0.000405	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	2.43e-05	0.000402	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.43e-05	0.000402	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	2.43e-05	0.000401	CbGpPWpGaD
Fluphenazine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.41e-05	0.000398	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	2.4e-05	0.000398	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	2.39e-05	0.000396	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.39e-05	0.000396	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.39e-05	0.000395	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.39e-05	0.000395	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.38e-05	0.000394	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.37e-05	0.000392	CbGpPWpGaD
Fluphenazine—CALM1—DAP12 interactions—IL6—acquired immunodeficiency syndrome	2.37e-05	0.000392	CbGpPWpGaD
Fluphenazine—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.37e-05	0.000392	CbGpPWpGaD
Fluphenazine—CALM2—DAP12 interactions—IL6—acquired immunodeficiency syndrome	2.37e-05	0.000392	CbGpPWpGaD
Fluphenazine—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.37e-05	0.000392	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	2.37e-05	0.000392	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	2.37e-05	0.000392	CbGpPWpGaD
Fluphenazine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.36e-05	0.000391	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.36e-05	0.00039	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.35e-05	0.000389	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	2.35e-05	0.000388	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	2.35e-05	0.000388	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.35e-05	0.000388	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	2.33e-05	0.000385	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	2.33e-05	0.000385	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	2.32e-05	0.000383	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	2.32e-05	0.000383	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.28e-05	0.000378	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IFNA1—acquired immunodeficiency syndrome	2.28e-05	0.000377	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.27e-05	0.000376	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—ALB—acquired immunodeficiency syndrome	2.22e-05	0.000367	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.22e-05	0.000367	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CD79A—acquired immunodeficiency syndrome	2.21e-05	0.000366	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.21e-05	0.000365	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IFNA1—acquired immunodeficiency syndrome	2.2e-05	0.000365	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IFNA1—acquired immunodeficiency syndrome	2.2e-05	0.000365	CbGpPWpGaD
Fluphenazine—CALM3—Disease—CXCR4—acquired immunodeficiency syndrome	2.2e-05	0.000364	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.19e-05	0.000362	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.18e-05	0.000361	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.18e-05	0.00036	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.17e-05	0.000359	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.17e-05	0.000359	CbGpPWpGaD
Fluphenazine—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	2.17e-05	0.000359	CbGpPWpGaD
Fluphenazine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	2.16e-05	0.000358	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.15e-05	0.000357	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.15e-05	0.000356	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.15e-05	0.000355	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.15e-05	0.000355	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.15e-05	0.000355	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—ALB—acquired immunodeficiency syndrome	2.14e-05	0.000355	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—ALB—acquired immunodeficiency syndrome	2.14e-05	0.000355	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CD79A—acquired immunodeficiency syndrome	2.14e-05	0.000354	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CD79A—acquired immunodeficiency syndrome	2.14e-05	0.000354	CbGpPWpGaD
Fluphenazine—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.14e-05	0.000354	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.14e-05	0.000354	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.13e-05	0.000353	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.13e-05	0.000353	CbGpPWpGaD
Fluphenazine—CALM2—Disease—CXCR4—acquired immunodeficiency syndrome	2.13e-05	0.000352	CbGpPWpGaD
Fluphenazine—CALM1—Disease—CXCR4—acquired immunodeficiency syndrome	2.13e-05	0.000352	CbGpPWpGaD
Fluphenazine—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	2.1e-05	0.000347	CbGpPWpGaD
Fluphenazine—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	2.1e-05	0.000347	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2e-05	0.000332	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.99e-05	0.000329	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.98e-05	0.000328	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.98e-05	0.000328	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.97e-05	0.000326	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.97e-05	0.000326	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.97e-05	0.000326	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.96e-05	0.000324	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.95e-05	0.000323	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.94e-05	0.000322	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.92e-05	0.000317	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.92e-05	0.000317	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.9e-05	0.000314	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.89e-05	0.000312	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.89e-05	0.000312	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.88e-05	0.000312	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.88e-05	0.000312	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.87e-05	0.00031	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.87e-05	0.000309	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.85e-05	0.000307	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.85e-05	0.000307	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.85e-05	0.000306	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.85e-05	0.000306	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.85e-05	0.000305	CbGpPWpGaD
Fluphenazine—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.84e-05	0.000305	CbGpPWpGaD
Fluphenazine—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.82e-05	0.000301	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.81e-05	0.000299	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CD40LG—acquired immunodeficiency syndrome	1.8e-05	0.000298	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—IL2—acquired immunodeficiency syndrome	1.8e-05	0.000297	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.79e-05	0.000297	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.79e-05	0.000295	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CSF2—acquired immunodeficiency syndrome	1.78e-05	0.000295	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CD8A—acquired immunodeficiency syndrome	1.78e-05	0.000295	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.76e-05	0.000291	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.75e-05	0.00029	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.75e-05	0.00029	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CD40LG—acquired immunodeficiency syndrome	1.74e-05	0.000289	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CD40LG—acquired immunodeficiency syndrome	1.74e-05	0.000289	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—IL2—acquired immunodeficiency syndrome	1.74e-05	0.000288	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—IL2—acquired immunodeficiency syndrome	1.74e-05	0.000288	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.73e-05	0.000286	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.73e-05	0.000286	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CSF2—acquired immunodeficiency syndrome	1.73e-05	0.000286	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CSF2—acquired immunodeficiency syndrome	1.73e-05	0.000286	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CD8A—acquired immunodeficiency syndrome	1.73e-05	0.000286	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CD8A—acquired immunodeficiency syndrome	1.73e-05	0.000286	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HLA-B—acquired immunodeficiency syndrome	1.72e-05	0.000284	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.71e-05	0.000283	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.7e-05	0.000282	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.7e-05	0.000282	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.69e-05	0.000279	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.69e-05	0.000279	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.69e-05	0.000279	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.69e-05	0.000279	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.67e-05	0.000277	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.67e-05	0.000276	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HLA-B—acquired immunodeficiency syndrome	1.66e-05	0.000275	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HLA-B—acquired immunodeficiency syndrome	1.66e-05	0.000275	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.65e-05	0.000273	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.64e-05	0.000271	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.63e-05	0.00027	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.63e-05	0.00027	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.63e-05	0.00027	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.62e-05	0.000269	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.61e-05	0.000267	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.61e-05	0.000267	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.61e-05	0.000266	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.6e-05	0.000265	CbGpPWpGaD
Fluphenazine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.58e-05	0.000262	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.58e-05	0.000262	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.58e-05	0.000262	CbGpPWpGaD
Fluphenazine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.58e-05	0.000261	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.54e-05	0.000255	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.54e-05	0.000255	CbGpPWpGaD
Fluphenazine—CALM3—Disease—CCR5—acquired immunodeficiency syndrome	1.51e-05	0.000249	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.49e-05	0.000246	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.49e-05	0.000246	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.49e-05	0.000246	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.49e-05	0.000246	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.47e-05	0.000243	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.46e-05	0.000242	CbGpPWpGaD
Fluphenazine—CALM1—Disease—CCR5—acquired immunodeficiency syndrome	1.46e-05	0.000241	CbGpPWpGaD
Fluphenazine—CALM2—Disease—CCR5—acquired immunodeficiency syndrome	1.46e-05	0.000241	CbGpPWpGaD
Fluphenazine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.45e-05	0.000241	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.44e-05	0.000238	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.43e-05	0.000237	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000237	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.41e-05	0.000234	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.41e-05	0.000233	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.41e-05	0.000233	CbGpPWpGaD
Fluphenazine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.39e-05	0.00023	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.39e-05	0.00023	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.39e-05	0.000229	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.37e-05	0.000226	CbGpPWpGaD
Fluphenazine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.37e-05	0.000226	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.29e-05	0.000214	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.28e-05	0.000212	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.27e-05	0.00021	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.27e-05	0.00021	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.26e-05	0.000209	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.26e-05	0.000209	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.25e-05	0.000206	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.24e-05	0.000206	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.24e-05	0.000205	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.22e-05	0.000202	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.17e-05	0.000194	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.16e-05	0.000191	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.15e-05	0.000191	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.15e-05	0.00019	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.14e-05	0.000189	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.13e-05	0.000187	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.13e-05	0.000187	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.13e-05	0.000187	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.12e-05	0.000185	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.12e-05	0.000185	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IFNG—acquired immunodeficiency syndrome	1.06e-05	0.000176	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.05e-05	0.000175	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000171	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IFNG—acquired immunodeficiency syndrome	1.03e-05	0.00017	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IFNG—acquired immunodeficiency syndrome	1.03e-05	0.00017	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CD4—acquired immunodeficiency syndrome	1.02e-05	0.00017	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.02e-05	0.000169	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.02e-05	0.000169	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.98e-06	0.000165	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.98e-06	0.000165	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CD4—acquired immunodeficiency syndrome	9.91e-06	0.000164	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CD4—acquired immunodeficiency syndrome	9.91e-06	0.000164	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.88e-06	0.000164	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	9.85e-06	0.000163	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.83e-06	0.000163	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.75e-06	0.000161	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.7e-06	0.000161	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—IL6—acquired immunodeficiency syndrome	9.51e-06	0.000157	CbGpPWpGaD
Fluphenazine—CALM3—Disease—CD4—acquired immunodeficiency syndrome	9.46e-06	0.000157	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL2—acquired immunodeficiency syndrome	9.43e-06	0.000156	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—IL6—acquired immunodeficiency syndrome	9.2e-06	0.000152	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—IL6—acquired immunodeficiency syndrome	9.2e-06	0.000152	CbGpPWpGaD
Fluphenazine—CALM2—Disease—CD4—acquired immunodeficiency syndrome	9.15e-06	0.000151	CbGpPWpGaD
Fluphenazine—CALM1—Disease—CD4—acquired immunodeficiency syndrome	9.15e-06	0.000151	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL2—acquired immunodeficiency syndrome	9.12e-06	0.000151	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL2—acquired immunodeficiency syndrome	9.12e-06	0.000151	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	9.05e-06	0.00015	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—ALB—acquired immunodeficiency syndrome	8.99e-06	0.000149	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—ALB—acquired immunodeficiency syndrome	8.69e-06	0.000144	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—ALB—acquired immunodeficiency syndrome	8.69e-06	0.000144	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.5e-06	0.000141	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.46e-06	0.00014	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.45e-06	0.00014	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.41e-06	0.000139	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.46e-06	0.000123	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.42e-06	0.000123	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.34e-06	0.000121	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.33e-06	0.000121	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.3e-06	0.000121	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.29e-06	0.000121	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	6.81e-06	0.000113	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.75e-06	0.000112	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.68e-06	0.000111	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.65e-06	0.00011	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	6.42e-06	0.000106	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.09e-06	0.000101	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.06e-06	0.0001	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.9e-06	9.75e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.9e-06	9.75e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.87e-06	9.71e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.87e-06	9.71e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.81e-06	9.61e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.73e-06	9.48e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6—acquired immunodeficiency syndrome	5.54e-06	9.17e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.44e-06	9e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6—acquired immunodeficiency syndrome	5.36e-06	8.87e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6—acquired immunodeficiency syndrome	5.36e-06	8.87e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6—acquired immunodeficiency syndrome	5.12e-06	8.46e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.99e-06	8.27e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.97e-06	8.22e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6—acquired immunodeficiency syndrome	4.95e-06	8.19e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6—acquired immunodeficiency syndrome	4.95e-06	8.19e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.39e-06	7.26e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.32e-06	7.14e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.31e-06	7.12e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.93e-06	6.5e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.58e-06	5.93e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.47e-06	5.73e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.47e-06	5.73e-05	CbGpPWpGaD
